BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21642390)

  • 1. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
    Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
    Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
    Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
    Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
    Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
    J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwann cell-conditioned medium inhibits angiogenesis.
    Huang D; Rutkowski JL; Brodeur GM; Chou PM; Kwiatkowski JL; Babbo A; Cohn SL
    Cancer Res; 2000 Nov; 60(21):5966-71. PubMed ID: 11085514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
    Mora J; Cheung NK; Juan G; Illei P; Cheung I; Akram M; Chi S; Ladanyi M; Cordon-Cardo C; Gerald WL
    Cancer Res; 2001 Sep; 61(18):6892-8. PubMed ID: 11559566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
    de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
    Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
    Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
    J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
    Liu S; Tian Y; Chlenski A; Yang Q; Salwen HR; Cohn SL
    Cancer Lett; 2005 Oct; 228(1-2):125-31. PubMed ID: 15935552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.
    Rogers DA; Schor NF
    Exp Cell Res; 2013 Mar; 319(5):660-9. PubMed ID: 23333500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
    Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
    FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tumoral glial precursor cells in neuroblastoma.
    Acosta S; Mayol G; Rodríguez E; Lavarino C; de Preter K; Kumps C; Garcia I; de Torres C; Mora J
    Cancer Lett; 2011 Dec; 312(1):73-81. PubMed ID: 21903323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
    Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
    Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
    Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
    Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin.
    Bourdeaut F; Ribeiro A; Paris R; Pierron G; Couturier J; Peuchmaur M; Delattre O
    Oncogene; 2008 May; 27(21):3066-71. PubMed ID: 18071318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
    Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
    J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
    Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
    Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Ransohoff RM; Ness JM; Colliver JA
    J Neuroimmunol; 2012 Feb; 243(1-2):81-8. PubMed ID: 22264765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.